The primary purpose of this 16-week maintenance study is to determine the safety and effectiveness of 8 mg per day sublingual buprenorphine as compared to 1 mg per day sublingual buprenorphine in decreasing illicit opiate use as measured by urine testing 3 times a week, retention rates, and opiate craving and global rating scores in patients who meet DSM-III-R criteria for opiate dependence. This data is from the background table, giving background characteristics of the study participants.

https://gist.github.com/sophburke/28350a4b56afc08cfd78fd17b3bb0552